Detailed financials available on request
This company is listed on the Mauritius stock exchange and is about to be listed on the Johannesburg Stock Exchange. It has huge presence internationally in the health industry and the revenue for the main company is estimated at US$ 27 million for 2016. Although the products have been distributed in SA since 2005 (mainly in the Eastern Cape), the company wants to expand rapidly into the other regions of SA as well and are therefore offering distribution licences within these regions to approved distributors. For an amount of R450,000, such a distributor will have the right to distribute the undermentioned products within the area, to any business or start a distribution business to the target areas. The existing products that form part of the distributorship are aimed at curbing illnesses like metabolic diseases, chronic inflammation, malabsorption, cardio-vascular disease, cancer, stress, cognitive disorders, weight reduction, sensual deficiencies and skin disorders. For more information, kindly contact the listing Broker.